Australia's Nufarm rises on obtaining commercial license from Yield10 Bioscience
** Shares of Nufarm NUF.AX rise as much as 1.1% to A$4.65,
their highest since July 4
** Co says Yield10 Bioscience YTEN.PK granted co with a
commercial license to omega-3 assets for producing oil in
camelina
** Adds, co has commenced negotiations for the purchase of
substantially all of Yield10 Bioscience's assets
** Stock has fallen 11.9% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on Nufarm
See all newsBrief: Nufarm Says For Fy26, Uebitda Is Expected To Be Between A$370 Million And A$380 Million
Australia's Nufarm falls after company flags one-off hits from cost-reduction measures
Australia's Nufarm gains as Morningstar remains upbeat on half-year earnings
Brief: Nufarm Posts H1 Adjusted Net Income AUD52 Million
Australia's Nufarm rises to 10-month high on strong HY earnings, lower annual capex outlook